On October 22, JACOBIO-B (01167) spent approximately HK$996,700 to repurchase 126,000 shares.
Kosco-B (01167) announced the repurchase of about 996,700 Hong Kong dollars on October 22, 2025, buying back 12...
JACOBIO-B(01167) announced on October 22, 2025 that it would spend about 99.67 million Hong Kong dollars to repurchase 126,000 shares.
Related Articles
Tonghua Dongbao Pharmaceutical (600867.SH): Recombinant Human Insulin Injection receives foreign drug registration certificate.
Beijing Foyou Pharma (601089.SH) has obtained the approval notice for the listing application of the raw material kelevoron.
Subsidiary of Shanghai Pharmaceuticals Holding (601607.SH) becomes the holder of the market authorization for Ammonium Sulphate Beicterb Tablets.
Tonghua Dongbao Pharmaceutical (600867.SH): Recombinant Human Insulin Injection receives foreign drug registration certificate.
Beijing Foyou Pharma (601089.SH) has obtained the approval notice for the listing application of the raw material kelevoron.
Subsidiary of Shanghai Pharmaceuticals Holding (601607.SH) becomes the holder of the market authorization for Ammonium Sulphate Beicterb Tablets.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
